Views & Analysis Transforming oncology with a pan-European approach to data s... Between genomic data, electronic health records and digital health tools, we have all the information we need to transform the fortunes of people living with cancer – but how do we ensure i
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
